A mouse model of shigellosis by intraperitoneal infection

Journal of Infectious Diseases

Volumn 209, Issue 2, 2014, Pages 203-215

  Yang, Jin Young ^a,b   Lee, Se Na ^a   Chang, Sun Young ^a,c   Ko, Hyun Jeong ^a,d   Ryu, Sangryeol ^b   Kweon, Mi Na ^a  

^a Seoul National University   (South Korea)

^b Seoul National University   (South Korea)

^c Ajou University   (South Korea)

^d Kangwon National University   (South Korea)

Author keywords

CCR2+ monocytes; Intraperitoneal route; Mouse model; S. flexneri; Shigellosis

Indexed keywords

ALPHA INTERFERON; AMPHIREGULIN; CD11B ANTIGEN; GAMMA INTERFERON; GAMMA INTERFERON INDUCIBLE PROTEIN 10; INTERLEUKIN 1ALPHA; INTERLEUKIN 1BETA; INTERLEUKIN 6; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MACROPHAGE INFLAMMATORY PROTEIN 1BETA; MONOCYTE CHEMOTACTIC PROTEIN 1; MONOCYTE CHEMOTACTIC PROTEIN 3; PADGEM PROTEIN; RANTES; SHIGELLA VACCINE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIMICROBIAL ACTIVITY; ARTICLE; BACTERIAL COLONIZATION; BACTERIAL SHEDDING; BACTERIAL STRAIN; BACTERIAL VIRULENCE; CELL HYPERPLASIA; CELL MIGRATION; CONTROLLED STUDY; DIARRHEA; DRUG EFFICACY; GENE EXPRESSION; GOBLET CELL; IMMUNOGENICITY; IMMUNOPATHOGENESIS; LAMINA PROPRIA; LARGE INTESTINE; MONOCYTE; MOUSE; NONHUMAN; PERITONITIS; PRIORITY JOURNAL; PROTEIN SECRETION; SEROSA; SHIGELLA FLEXNERI; SHIGELLOSIS; STOMACH PROTECTION; TYPE III SECRETION SYSTEM; VACCINATION; WEIGHT REDUCTION;

EID: 84891514016     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1093/infdis/jit399     Document Type: Article

References (39)

1. Parsot C, Sansonetti PJ. Invasion and the pathogenesis of Shigella infections. Curr Top Microbiol Immunol 1996; 209:25-42
2. Kotloff KL, Winickoff JP, Ivanoff B, et al. Global burden of Shigella infections: Implications for vaccine development and implementation of control strategies. BullWorld Health Organ 1999; 77:651-66
3. Galan JE, Wolf-Watz H. Protein delivery into eukaryotic cells by type III secretion machines. Nature 2006; 444:567-73
4. Ogawa M, Handa Y, Ashida H, Suzuki M, Sasakawa C. The versatility of Shigella effectors. Nat Rev Microbiol 2008; 6:11-6
5. Yoshida S, Handa Y, Suzuki T, et al. Microtubule-severing activity of Shigella is pivotal for intercellular spreading. Science 2006; 314: 985-9
6. Fukumatsu M, Ogawa M, Arakawa S, et al. Shigella targets epithelial tricellular junctions and uses a noncanonical clathrin-dependent endocytic pathway to spread between cells. Cell Host Microbe 2012; 11:325-36
7. Niyogi SK. Shigellosis. J Microbiol 2005; 43:133-43
8. Islam D, Veress B, Bardhan PK, Lindberg AA, Christensson B. In situ characterization of inflammatory responses in the rectal mucosae of patients with shigellosis. Infect Immun 1997; 65:739-49
9. Sansonetti PJ. Shigellosis: An old disease in new clothes? PLoS Med 2006; 3:e354
10. Suzuki T, Franchi L, Toma C, et al. Differential regulation of caspase-1 activation, pyroptosis, and autophagy via Ipaf and ASC in Shigella-infected macrophages. PLoS Pathogens 2007; 3:e111
11. Arm HG, Floyd TM, Faber JE, Hayes Jr. Use of ligated segments of rabbit small intestine in experimental shigellosis. J Bacteriol 1965; 89:803-9
12. Sereny B. Experimental Shigella keratoconjunctivitis; a preliminary report. Acta Microbiol Acad Sci Hung 1955; 2:293-6
13. Kuss SK, Best GT, Etheredge CA, et al. Intestinal microbiota promote enteric virus replication and systemic pathogenesis. Science 2011; 334:249-52
14. Cash HL, Whitham CV, Behrendt CL, Hooper LV. Symbiotic bacteria direct expression of an intestinal bactericidal lectin. Science 2006; 313:1126-30
15. Cornelis GR. The type III secretion injectisome. Nat Rev Microbiol 2006; 4:811-25
16. Flo TH, Smith KD, Sato S, et al. Lipocalin 2 mediates an innate immune response to bacterial infection by sequestrating iron. Nature 2004; 432: 917-21
17. Nisapakultorn K, Ross KF, Herzberg MC. Calprotectin expression inhibits bacterial binding to mucosal epithelial cells. Infect Immun 2001; 69:3692-6
18. Shao J, Sheng H. Amphiregulin promotes intestinal epithelial regeneration: Roles of intestinal subepithelial myofibroblasts. Endocrinology 2010; 151:3728-37
19. Ridger VC, Hellewell PG, Norman KE. L-And P-selectins collaborate to support leukocyte rolling in vivo when high-Affinity P-selectin-Pselectin glycoprotein ligand-1 interaction is inhibited. Am J Pathol 2005; 166:945-52
20. Barzu S, Arondel J, Guillot S, Sansonetti PJ, Phalipon A. Immunogenicity of IpaC-hybrid proteins expressed in the Shigella flexneri 2a vaccine candidate SC602. Infect Immun 1998; 66:77-82
21. Mc GC, Floyd TM. Studies on experimental shigellosis: I. Shigella infections of normal mice. J Exp Med 1958; 108:269-76
22. Shim DH, Ryu S, Kweon MN. Defensins play a crucial role in protecting mice against oral Shigella flexneri infection. Biochem Biophys Res Commun 2010; 401:554-60
23. Shim DH, Suzuki T, Chang SY, et al. New animal model of shigellosis in the guinea pig: Its usefulness for protective efficacy studies. Journal of immunology 2007; 178:2476-82
24. Osman NE, Westrom B, Karlsson B. Serosal but not mucosal endotoxin exposure increases intestinal permeability in vitro in the rat. Scand J Gastroenterol 1998; 33:1170-4
25. Anand BS, Malhotra V, Bhattacharya SK, et al. Rectal histology in acute bacillary dysentery. Gastroenterology 1986; 90:654-60
26. Bergstrom KS, Guttman JA, Rumi M, et al. Modulation of intestinal goblet cell function during infection by an attaching and effacing bacterial pathogen. Infect Immun 2008; 76:796-811
27. Bergstrom KS, Kissoon-Singh V, Gibson DL, et al. Muc2 protects against lethal infectious colitis by disassociating pathogenic and commensal bacteria from the colonic mucosa. PLoS pathogens 2010; 6: E1000902
28. Van der Sluis M, De Koning BA, De Bruijn AC, et al. Muc2-deficient mice spontaneously develop colitis, indicating that MUC2 is critical for colonic protection. Gastroenterology 2006; 131:117-29
29. Ashida H, OgawaM,KimM, et al. Shigella deploy multiple countermeasures against host innate immune responses. Curr OpinMicrobiol 2011; 14:16-23
30. Auffray C, Sieweke MH, Geissmann F. Blood monocytes: Development, heterogeneity, and relationship with dendritic cells. Annu Rev Immunol 2009; 27:669-92
31. Serbina NV, Jia T, Hohl TM, Pamer EG. Monocyte-mediated defense against microbial pathogens. Annu Rev Immunol 2008; 26:421-52
32. Serbina NV, Salazar-Mather TP, Biron CA, Kuziel WA, Pamer EG. TNF/iNOS-producing dendritic cells mediate innate immune defense against bacterial infection. Immunity 2003; 19:59-70
33. Copin R, De Baetselier P, Carlier Y, Letesson JJ, Muraille E. MyD88-dependent activation of B220-CD11b+LY-6C+ dendritic cells during Brucella melitensis infection. JImmunol 2007; 178:5182-91
34. Skold M, Behar SM. Tuberculosis triggers a tissue-dependent program of differentiation and acquisition of effector functions by circulating monocytes. J Immunol 2008; 181:6349-60
35. Tsou CL, Peters W, Si Y, et al. Critical roles for CCR2 and MCP-3 in monocyte mobilization from bone marrow and recruitment to inflammatory sites. J Clin Invest 2007; 117:902-9
36. Fernandez MI, Thuizat A, Pedron T, Neutra M, Phalipon A, Sansonetti PJ. A newborn mouse model for the study of intestinal pathogenesis of shigellosis. CellMicrobiol 2003; 5:481-91
37. Sansonetti PJ, Arondel J, Cantey JR, Prevost MC, Huerre M. Infection of rabbit Peyer's patches by Shigella flexneri: Effect of adhesive or invasive bacterial phenotypes on follicle-Associated epithelium. Infect Immun 1996; 64:2752-64
38. Voino-Yasenetsky MV, Voino-Yasenetskaya MK. Experimental pneumonia caused by bacteria of the Shigella group. Acta Morphol Acad Sci Hung 1962; 11:439-54
39. Shim DH, Chang SY, Park SM, et al. Immunogenicity and protective efficacy offered by a ribosomal-based vaccine from Shigella flexneri 2a. Vaccine 2007; 25:4828-36